CINP 2026 World Congress to Open in Glasgow with SCNP Joint Meeting

Priya Nair
Priya Nair
Editor, Healthcare & Life Sciences
Updated on June 22, 2026
CINP World Congress - Collegium Int'l Neuro-Psycopharmacologieum CINP World Congress - Collegium Int'l Neuro-Psycopharmacologieum

Glasgow, United Kingdom — June 22, 2026 — The 37th World Congress of Neuropsychopharmacology, CINP 2026, will commence on June 26, 2026, in Glasgow, United Kingdom, featuring a joint meeting with the Scandinavian College of Neuropsychopharmacology (SCNP).

Advancing Brain Health and Interdisciplinary Collaboration

The CINP World Congress - Collegium Int'l Neuro-Psycopharmacologieum (CINP 2026) is themed 'Advancing Brain Health Together'. It aims to advance worldwide neuroscience and education for brain and mental health. The congress will serve as a forum for interdisciplinary discussion of recent breakthroughs and developments. It will incorporate a dedicated track for early career clinicians and researchers, offering opportunities to network with global leaders in the field.

The event is designed to bring together experts from research and medical institutions, leading worldwide regulatory authorities, and major pharmaceutical firms. This assembly seeks to establish a framework for cohesive collaboration between academia, industry, and governmental institutions toward the innovative development and appropriate use of central nervous system (CNS) drugs. The congress will be held at the Scottish Events Campus (SEC) and is organized by AIM Group International, Vienna Office.

Target Audience and Concurrent Programming

Approximately 1500 delegates are expected for the 2026 congress. The target audience includes experts from research and medical institutions, leading worldwide regulatory authorities, major pharmaceutical firms, clinicians, and researchers. The event also specifically focuses on early career clinicians and researchers, aiming to gather the global neuropsychopharmacology community.

As a Joint Meeting with the Scandinavian College of Neuropsychopharmacology (SCNP), the CINP 2026 Congress will host a dedicated one-day meeting on Friday, June 26, 2026, open to all joint meeting delegates. The main CINP Congress programme will also feature a Scandinavian Plenary Lecture, several SCNP-led symposia, and an SCNP Early Career Symposium. The President's Recognition for Young Investigators diploma will be awarded at the event.

Participation and Logistics

Registration for CINP 2026 remains available. The Standard Registration Deadline was June 9, 2026, after which Late registration fees apply. Group registration permits purchasing tickets at a flat fee of GBP 800 per person for 2026, with participants' names to have been submitted by May 15, 2026. Payment can be made via bank transfer.

Cancellations requested by March 24, 2026, were eligible for a refund minus a GBP 50 administrative fee. Requests received after March 24, 2026, are not eligible for refunds. Name changes are permitted with a GBP 50 fee. CINP Members are invited to a reception on June 27, 2026, free of charge, in the CINP Members' Lounge at the Congress Venue. The deadline for abstract submission to CINP 2026 was extended to January 12, 2026. Submissions were welcomed for Featured Communication (Oral Presentation, 15 minutes), Data Blitz (Oral Presentation, 6 minutes), and Posters displayed in the Exhibition Area.

Further details and registration information are available at https://cinp2026.org.

Official Event Access
CINP World Congress - Collegium Int'l Neuro-Psycopharmacologieum
2026-06-26
Glasgow, United Kingdom
Pharmaceuticals Healthcare Scientific Research